Clinical trial
Fixed-Dose Netupitant and Palonosetron for Chronic Nausea and Vomiting in Cancer Patients
NCT03040726 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fixed-Dose Netupitant and Palonosetron for Chronic Nausea and Vomiting in Cancer Patients
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 3, 2017
- Completion date
- February 14, 2022
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.